Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Long-Term Debt Repayments (2017 - 2025)

Selectis Health's Long-Term Debt Repayments history spans 13 years, with the latest figure at -$357084.0 for Q3 2025.

  • For Q3 2025, Long-Term Debt Repayments rose 73.47% year-over-year to -$357084.0; the TTM value through Sep 2025 reached -$2.3 million, up 16.73%, while the annual FY2017 figure was $720044.0, 2320.56% up from the prior year.
  • Long-Term Debt Repayments for Q3 2025 was -$357084.0 at Selectis Health, down from -$348166.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at -$223483.0 in Q1 2021 and bottomed at -$7.4 million in Q3 2021.
  • The 5-year median for Long-Term Debt Repayments is -$404750.0 (2024), against an average of -$1.0 million.
  • The largest annual shift saw Long-Term Debt Repayments crashed 2034.84% in 2021 before it surged 73.47% in 2025.
  • A 5-year view of Long-Term Debt Repayments shows it stood at -$7.4 million in 2021, then skyrocketed by 91.8% to -$609089.0 in 2022, then grew by 1.96% to -$597156.0 in 2023, then crashed by 125.4% to -$1.3 million in 2024, then soared by 73.47% to -$357084.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Long-Term Debt Repayments are -$357084.0 (Q3 2025), -$348166.0 (Q2 2025), and -$245697.0 (Q1 2025).